Leaky Gut in IBD: Intestinal Barrier–Gut Microbiota Interaction
Author(s) -
Shunying Yu,
Yibin Sun,
Xinyu Shao,
Yuqing Zhou,
Yang Yu,
Xiaoyi Kuai,
Chunli Zhou
Publication year - 2022
Publication title -
journal of microbiology and biotechnology
Language(s) - German
Resource type - Journals
SCImago Journal Rank - 0.601
H-Index - 64
eISSN - 1738-8872
pISSN - 1017-7825
DOI - 10.4014/jmb.2203.03022
Subject(s) - gut flora , enteric nervous system , immune system , gut–brain axis , inflammatory bowel disease , gastrointestinal tract , barrier function , biology , tight junction , immunology , homeostasis , gut associated lymphoid tissue , intestinal mucosa , pathogenesis , disease , neuroscience , medicine , microbiology and biotechnology , pathology , biochemistry
Inflammatory bowel disease (IBD) is a global disease that is in increasing incidence. The gut, which contains the largest amount of lymphoid tissue in the human body, as well as a wide range of nervous system components, is integral in ensuring intestinal homeostasis and function. By interacting with gut microbiota, immune cells, and the enteric nervous system, the intestinal barrier, which is a solid barrier, protects the intestinal tract from the external environment, thereby maintaining homeostasis throughout the body. Destruction of the intestinal barrier is referred to as developing a "leaky gut," which causes a series of changes relating to the occurrence of IBD. Changes in the interactions between the intestinal barrier and gut microbiota are particularly crucial in the development of IBD. Exploring the leaky gut and its interaction with the gut microbiota, immune cells, and the neuroimmune system may help further explain the pathogenesis of IBD and provide potential therapeutic methods for future use.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom